Identification of specific targets for the gut mucosal defense factor intestinal alkaline phosphatase

被引:85
作者
Chen, Kathryn T. [1 ,3 ]
Malo, Madhu S. [1 ]
Moss, Angela K. [1 ]
Zeller, Skye [2 ]
Johnson, Paul [2 ]
Ebrahimi, Farzad [1 ]
Mostafa, Golam [1 ]
Alam, Sayeda N. [1 ]
Ramasamy, Sundaram [1 ]
Warren, H. Shaw [2 ]
Hohmann, Elizabeth L. [2 ]
Hodin, Richard A. [1 ]
机构
[1] Harvard Univ, Dept Surg, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA
[2] Harvard Univ, Div Infect Dis, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA
[3] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2010年 / 299卷 / 02期
关键词
lipopolysaccharide; Toll-like receptors; ANTIBIOTIC-INDUCED RELEASE; SALMONELLA-TYPHIMURIUM; PARENTERAL-NUTRITION; ESCHERICHIA-COLI; BACTERIAL-DNA; RECEPTOR; LIPOPOLYSACCHARIDE; ENDOTOXIN; NOD2/CARD15; RECOGNITION;
D O I
10.1152/ajpgi.00364.2009
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chen KT, Malo MS, Moss AK, Zeller S, Johnson P, Ebrahimi F, Mostafa G, Alam SN, Ramasamy S, Warren HS, Hohmann EL, Hodin RA. Identification of specific targets for the gut mucosal defense factor intestinal alkaline phosphatase. Am J Physiol Gastro-intest Liver Physiol 299: G467-G475, 2010. First published May 20, 2010; doi: 10.1152/ajpgi.00364.2009.-Intestinal alkaline phosphatase (IAP) is a small intestinal brush border enzyme that has been shown to function as a gut mucosal defense factor, but its precise mechanism of action remains unclear. We investigated the effects of IAP on specific bacteria and bacterial components to determine its molecular targets. Purulent fluid from a cecal ligation and puncture model, specific live and heat-killed bacteria (Escherichia coli, Salmonella typhimurium, and Listeria monocytogenes), and a variety of proinflammatory ligands (LPS, CpG DNA, Pam-3-Cys, flagellin, and TNF) were incubated with or without calf IAP (cIAP). Phosphate release was determined by using a malachite green assay. The various fluids were applied to target cells (THP-1, parent HT-29, and IAP-expressing HT-29 cells) and IL-8 secretion measured by ELISA. cIAP inhibited IL-8 induction by purulent fluid in THP-1 cells by >35% (P < 0.005). HT29-IAP cells had a reduced IL-8 response specifically to gram-negative bacteria; >90% reduction compared with parent cells (P < 0.005). cIAP had no effect on live bacteria but attenuated IL-8 induction by heat-killed bacteria by >40% (P < 0.005). cIAP exposure to LPS and CpG DNA caused phosphate release and reduced IL-8 in cell culture by >50% (P < 0.005). Flagellin exposure to cIAP also resulted in reduced IL-8 secretion by >40% (P < 0.005). In contrast, cIAP had no effect on TNF or Pam-3-Cys. The mechanism of IAP action appears to be through dephosphorylation of specific bacterial components, including LPS, CpG DNA, and flagellin, and not on live bacteria themselves. IAP likely targets these bacterially derived molecules in its role as a gut mucosal defense factor.
引用
收藏
页码:G467 / G475
页数:9
相关论文
共 52 条
[1]   Lipopolysaccharide interaction with cell surface toll-like receptor 4-MD-2: Higher affinity than that with MD-2 or CD14 [J].
Akashi, S ;
Saitoh, S ;
Wakabayashi, Y ;
Kikuchi, T ;
Takamura, N ;
Nagai, Y ;
Kusumoto, Y ;
Fukase, K ;
Kusumoto, S ;
Adachi, Y ;
Kosugi, A ;
Miyake, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (07) :1035-1042
[2]   Structural requirements for TLR4-mediated LPS signalling:: a biological role for LPS modifications [J].
Bäckhed, F ;
Normark, S ;
Schweda, EKH ;
Oscarson, S ;
Richter-Dahlfors, A .
MICROBES AND INFECTION, 2003, 5 (12) :1057-1063
[3]   Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota [J].
Bates, Jennifer M. ;
Akerlund, Janie ;
Mittge, Erika ;
Guillemin, Karen .
CELL HOST & MICROBE, 2007, 2 (06) :371-382
[4]   Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition [J].
Bauer, S ;
Kirschning, CJ ;
Häcker, H ;
Redecke, V ;
Hausmann, S ;
Akira, S ;
Wagner, H ;
Lipford, GB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9237-9242
[5]   Removal of phosphate from lipid a as a strategy to detoxify lipopolysaccharide [J].
Bentala, H ;
Verweij, WR ;
Huizinga-Van der Vlag, A ;
van Loenen-Weemaes, AM ;
Meijer, DKF ;
Poelstra, K .
SHOCK, 2002, 18 (06) :561-566
[6]   Calf intestinal alkaline phosphatase, a novel therapeutic drug for lipopolysaccharide (LPS)-mediated diseases, attenuates LPS toxicity in mice and piglets [J].
Beumer, C ;
Wulferink, M ;
Raaben, W ;
Fiechter, D ;
Brands, R ;
Seinen, W .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (02) :737-744
[7]   Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial [J].
Bozzetti, F ;
Braga, M ;
Gianotti, L ;
Gavazzi, C ;
Mariani, L .
LANCET, 2001, 358 (9292) :1487-1492
[8]   Early postoperative enteral nutrition improves gut oxygenation and reduces costs compared with total parenteral nutrition [J].
Braga, M ;
Gianotti, L ;
Gentilini, O ;
Parisi, V ;
Salis, C ;
Di Carlo, V .
CRITICAL CARE MEDICINE, 2001, 29 (02) :242-248
[9]   The pre-ligand binding assembly domain: a potential target of inhibition of tumour necrosis factor receptor function [J].
Chan, FKM .
ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 :50-53
[10]   Signaling by the TNF receptor superfamily and T cell homeostasis [J].
Chan, FKM ;
Siegel, RM ;
Lenardo, MJ .
IMMUNITY, 2000, 13 (04) :419-422